AMUNDI ETF Series. AMUNDI Hang Seng HK 35 Index ETF. AMUNDI FTSE China A50 Index ETF. Announcement Amendment to investment restrictions disclosure

Similar documents
Harvest MSCI China A 50 Index ETF. (RMB Counter Stock Code: HKD Counter Stock Code: 03118)

ChinaAMC CSI 300 Index ETF (the CSI 300 ETF ) RMB Counter Stock Code: HKD Counter Stock Code: 03188

Announcement Change of Directors and Update of Offering Documents

Announcement on Amendments to (i) Trustee s Liabilities; (ii) Investment Restrictions; (iii) Manager s Disclosures; (iv) Profiles

GFI ETF SERIES (the Trust )

Amundi Hong Kong Limited 22 March 2019

Hang Seng Investment Index Funds Series II. Hang Seng Index ETF (Stock Code: 2833) (the Fund )

State Street Global Advisors Asia Limited State Street Trust (HK) Limited Underlying Index:

a sub-fund of the ishares Asia Trust (the Trust )

The details and the conditions on which such waiver is granted are as described in section 5 below;

Haitong China RMB Income Fund ( Sub-Fund ), a sub-fund of Haitong RMB Investment Fund Series. NOTICE TO UNITHOLDERS 20 June 2014

(*This is a synthetic product) (each a Terminating Product, collectively the Terminating Products )

(each a Sub-Fund, collectively the Sub-Funds )

Terminating Investment Fund Final Distribution Final Distribution per Unit. Horizons S&P Asia ex JANZ Financials ETF HK$4,630, HK$23.

CSOP ETF SERIES ANNOUNCEMENT ADDITION OF A NEW HONG KONG DOLLAR COUNTER OF CSOP FTSE CHINA A50 ETF UNDER DUAL COUNTER MODEL. effective 8 November 2012

Hang Seng Investment Index Funds Series II. Hang Seng Index ETF (Stock Code: 2833) (the Fund ) Notice to Unitholders

Terminating Investment Fund Further distribution Further distribution per Unit Horizons S&P Asia ex JANZ Financials ETF HK$ 40, HK$ 0.

Hang Seng Investment Index Funds Series II. Hang Seng Index ETF (HKD Counter Stock Code: / RMB Counter Stock Code: 82833) (the Fund )

Hang Seng Investment Index Funds Series Hang Seng H-Share Index ETF (Stock Code: 2828) (the Fund ) Notice to Unitholders

MAIN\CHWINN\ _1.docx 2

Ping An of China CSI HK Dividend ETF Stock Code: 3070

IMPORTANT: THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. IF IN DOUBT, PLEASE SEEK PROFESSIONAL ADVICE.

Amundi Hong Kong Limited 22 March 2019

Hang Seng Investment Index Funds Series II Hang Seng Index ETF (Stock Code: 2833) (the Fund ) Notice to Unitholders

Renminbi ( RMB ) RMB counter Hong Kong dollars ( HKD ) HKD counter

XIE Shares India (Nifty 50) ETF* (*This is a synthetic ETF) (Stock Code: 3091)

Guotai Junan Investment Funds

Hang Seng Investment Index Funds Series III Hang Seng FTSE China 25 Index ETF (Stock Code: 2838) (the Fund ) Notice to Unitholders

Hang Seng Investment Index Funds Series Hang Seng H-Share Index ETF (Stock Code: 2828) (the Fund ) Notice to Unitholders

PRODUCT KEY FACTS. Quick Facts. What is this product?

IMPORTANT: THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. IF IN DOUBT, PLEASE SEEK PROFESSIONAL ADVICE.

Hang Seng Investment Index Fund Series. Hang Seng H-Share Index ETF (HKD Counter Stock Code: / RMB Counter Stock Code: 82828) (the Fund )

ishares Asia Trust A Hong Kong unit trust authorised under Section 104 of the Securities and Futures Ordinance (Cap.

IMPORTANT If you are in any doubt about the contents of this Prospectus, you should seek independent professional financial advice.

PRODUCT KEY FACTS STATEMENT

Overview of ETF Market in Hong Kong

Hang Seng H-Share Index ETF (stock code : 2828) Hong Kong Offering Document. 19 November Hang Seng Investment Management Limited

Hang Seng Investment Series (the Series )

PRODUCT KEY FACTS STATEMENT

STATE STREET GLOBAL ADVISORS

PRODUCT HIGHLIGHTS SHEET

PRODUCT KEY FACTS W.I.S.E. SSE 50 China Tracker

The Manager does not intend to pay or make any distributions or dividends Financial year end:

as Offeror and Product Arranger Hang Seng Non-Capital Protected Unlisted Gold Linked Deposits ( Hang Seng GLDs )

MIRAE ASSET HORIZONS EXCHANGE TRADED FUNDS SERIES

PRODUCT KEY FACTS ChinaAMC Hang Seng Stock Connect Hong Kong SmallCap Index ETF A Sub-fund established under the ChinaAMC Global ETF Series

CSOP Asset Management Limited 30 April 2018

The Manager does not intend to pay or make any distributions or dividends Financial year end:

STATE STREET GLOBAL ADVISORS

Hang Seng China A Industry Top Index Fund

Vanguard Investments Hong Kong Limited May 2018

PRODUCT KEY FACTS ChinaAMC Direxion Hang Seng Index Daily (-1x) Inverse Product

Equity Linked Deposits (Put Option)

Haitong CSI300 Index ETF (the Sub-Fund )

KODEX HSI FUTURES ETF (HKD Counter Stock Code: 03124) KODEX HSI FUTURES RMB FX ETF (HKD Counter Stock Code: 03134) SUB-FUNDS OF SAMSUNG ETFs TRUST

BMO Global Asset Management (Asia) Limited 20 April 2018

PROSPECTUS VANGUARD ETF SERIES

PRODUCT KEY FACTS W.I.S.E. - CSI HK 100 Tracker TM

The Vanguard Group, Inc. 3 June 2014

Wing Lung Bank Limited

Unlisted Structured Products Programme (Programme)

as Issuer and Product Arranger

PRODUCT KEY FACTS STATEMENT

CSOP China 5-Year Treasury Bond ETF HKEx Listed. Direct access to China onshore RMB treasury bonds.

1.09% Trading currency: Hong Kong Dollars (HK$) -1.09% Exchange listing: SEHK Main Board

PRODUCT KEY FACTS Samsung HSCEI Daily (-1x) Inverse Product

Ping An of China CSI HK Dividend ETF (Stock Code: 3070) Ping An of China CSI 5-10Y CGB ETF (Stock Code: 3080) (Sub-Funds of Ping An of China Trust)

(1) Change applicable to JPMorgan Europe High Yield Bond Fund

Annually at the Manager s discretion (May in each year) Financial year end of.

Premia Partners Company Limited 13 February 2018

ChinaAMC Leveraged/Inverse Series

as Issuer and Product Arranger


ChinaAMC Leveraged/Inverse Series

Wing Lung Bank Limited

as Issuer and Product Arranger

ETF Securities (HK) Limited HSBC Institutional Trust Services (Asia) Limited

Dow Jones Emerging ASEAN Titans 100 Index. Premia Partners Company Limited 30 July 2018

ChinaAMC Leveraged/Inverse Series

Non-Principal Protected Unlisted Equity Linked Investment Programme (Programme)

PRODUCT HIGHLIGHTS SHEET

Listing of Debt Securities for Professional Investors on The Stock Exchange of Hong Kong Limited Hong Kong Shanghai Beijing Yangon

CSOP LEVERAGED AND INVERSE SERIES (An umbrella unit trust established in Hong Kong)

Launch Announcement for Warrants to be issued by

CENTURY SUNSHINE ECOLOGICAL TECHNOLOGY HOLDINGS LIMITED

Schroder International Selection Fund Hong Kong Covering Document February 2018 Edition Prospectus June 2017 Edition (Version 1)

ChinaAMC ETF Series ChinaAMC CES China A80 Index ETF. Unaudited Semi-Annual Report. For the period from 1 January 2018 to 30 June 2018

ISSUE OF CONVERTIBLE BONDS

MACQUARIE STRUCTURED PRODUCTS ASIA LIMITED MACQUARIE BANK LIMITED

BANK OF CHINA (HONG KONG) LIMITED

as Issuer The Hongkong and Shanghai Banking Corporation Limited as Product Arranger for the unlisted structured products programme (Programme)

Issuer and Product Arranger

The SFC s Authorization, Compliance Requirements and Compliance Issues on Exchange Traded Funds ( ETFs )

BNP Paribas L1. Prospectus. Abbreviated as BNPP L1. An open-ended investment company incorporated under Luxembourg law

INTERIM FINANCIAL REPORT

ChinaAMC Leveraged/Inverse Series

Enhanced Investment Products Limited 14 November 2016

IMPORTANT NOTICE NOT FOR DISTRIBUTION TO ANY PERSON OR ADDRESS IN THE UNITED STATES

(Incorporated in the Cayman Islands with limited liability)

Transcription:

IMPORTANT: The Stock Exchange of Hong Kong Limited (the SEHK ), Hong Kong Exchanges and Clearing Limited ( HKEx ), the Securities and Futures Commission ( SFC ) and the Hong Kong Securities Clearing Company Limited take no responsibility for the contents of this Announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Announcement. The Manager accepts full responsibility for the accuracy of the information contained in this Announcement as at the date of publication, and confirms, having made all reasonable enquiries, that to the best of its knowledge and belief, there are no other facts the omission of which would make any statement misleading and opinions expressed in this Announcement have been arrived at after due and careful consideration. SFC authorisation is not a recommendation or endorsement of a scheme nor does it guarantee the commercial merits of a scheme or its performance. It does not mean the scheme is suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors. If you are in doubt about the contents of this Announcement, you should consult your stockbroker, bank manager, solicitor, accountant or other professional adviser. AMUNDI ETF Series (a Hong Kong unit trust which is authorised under Section 104 of the Securities and Futures Ordinance (Cap. 571) of Hong Kong) AMUNDI Hang Seng HK 35 Index ETF (HKD Counter Stock Code: 03012) (RMB Counter Stock Code: 83012) AMUNDI FTSE China A50 Index ETF (HKD Counter Stock Code: 02843) (RMB Counter Stock Code: 82843) (each a Sub-Fund and collectively the Sub-Funds ) Announcement Amendment to investment restrictions disclosure Unless otherwise stated, capitalised terms used in this Announcement shall have the same meaning ascribed to them in the prospectus of the Sub-Funds dated 26 October 2016 (the Prospectus ). The Manager of the Sub-Funds, (the Manager ) hereby announces that, effective from the date of this Announcement, the following amendments will be made to the investment restrictions disclosure in the Prospectus (the Amendments ): A. Borrowing restriction The Prospectus currently discloses that borrowing against the assets of each Sub-Fund is allowed up to a maximum of 25% of its latest available Net Asset Value. The disclosure will be amended to reflect that borrowing against the assets of each Sub-Fund is allowed up to a maximum of 10% of its latest available Net Asset Value and that borrowing against assets of a Sub-Fund for investment purposes is not permitted. B. Restriction to investment in unlisted or unquoted investments The Prospectus currently discloses that not more than 15% of the Net Asset Value of a Sub-Fund may be invested in Securities which are neither listed, quoted nor dealt in on a stock exchange, overthe-counter market or other organised securities market which is open to the international public and on which such Securities are regularly traded. 1

The disclosure will be amended to reflect that not more that 10% of the Net Asset Value of a Sub- Fund may be invested in such investments. C. Restriction to investment in Commodities (as defined below) The Prospectus currently discloses that not more than 20% of the Net Asset Value of a Sub-Fund may be invest in physical commodities (including gold, silver, platinum or other bullion) or any other commodity-based investments (excluding, for this purpose, Securities of companies engaged in producing, processing or trading in commodities) ( Commodities ). The disclosure will be amended to reflect that a Sub-Fund shall not invest in any Commodities. D. Diversification requirements The Prospectus currently discloses that not more than 10% of the Net Asset Value of a Sub-Fund may be invested in Securities (other than Government and other public securities) issued by any single issuer, save as permitted by Chapter 8.6(h) and as varied by paragraph 11 of Appendix I (Guidelines for regulating index tracking exchange traded funds) of the Code of Unit Trusts and Mutual Funds. The disclosure will be revised to reflect that, notwithstanding the foregoing, a Sub-Fund s holdings of Securities (other than Government and other public securities) of any single issuer shall not exceed 20% (or 35% in exceptional circumstances such as when the Security is highly dominant in the regulated market in which it trades, provided that at any one time a Sub-Fund may only hold Securities of one single issuer up to the 35% limit) of its latest available Net Asset Value. E. Impact to the Sub-Funds The Amendments are being made as the revised disclosure reflects the current practice of the Sub- Funds more accurately. Since the inception of the Sub-Funds, none of the Sub-Funds has: (i) engaged in borrowing; (ii) invested in any unlisted or unquoted investments referred to in section B above; (iii) invested in any Commodities; or (iv) held Securities (other than Government and other public securities) of any single issuer exceeding 20% (or 35% where that proves to be justified by exceptional market conditions) of its latest available Net Asset Value. As such, (i) other than the Amendments, the investment objective and strategy of the Sub-Funds will remain unchanged; (ii) the Amendments will not amount to material change to the Sub-Funds; (iii) there will be no material change or increase in the overall risk profile of the Sub-Funds following the Amendments; and (iv) the Amendments will not materially prejudice the interests of Unitholders. F. Prospectus and the Product Key Facts Statements The Amendments will be reflected in the revised Prospectus (by way of addendum), which will be published together with the updated Product Key Facts Statements of the Sub-Funds and this Announcement on the Sub-Funds website at www.amundietf.com.hk (this website has not been reviewed by the SFC) and Hong Kong Exchanges and Clearing Limited s website at www.hkex.com.hk. Investors who have any enquiries regarding the above may contact the Manager at 901 908, One Pacific Place, 88 Queensway, Hong Kong or at (852) 2521 4231 during normal office hours. as Manager of Amundi ETF Series and the Sub-Funds 21 November 2018 2

IMPORTANT: The Stock Exchange of Hong Kong Limited (the SEHK ), Hong Kong Exchanges and Clearing Limited ( HKEx ), the Securities and Futures Commission ( SFC ) and the Hong Kong Securities Clearing Company Limited take no responsibility for the contents of this Announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Announcement. The Manager accepts full responsibility for the accuracy of the information contained in this Announcement as at the date of publication, and confirms, having made all reasonable enquiries, that to the best of its knowledge and belief, there are no other facts the omission of which would make any statement misleading and opinions expressed in this Announcement have been arrived at after due and careful consideration. SFC authorisation is not a recommendation or endorsement of a scheme nor does it guarantee the commercial merits of a scheme or its performance. It does not mean the scheme is suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors. If you are in doubt about the contents of this Announcement, you should consult your stockbroker, bank manager, solicitor, accountant or other professional adviser. AMUNDI ETF Series (a Hong Kong unit trust which is authorised under Section 104 of the Securities and Futures Ordinance (Cap. 571) of Hong Kong) AMUNDI Hang Seng HK 35 Index ETF (HKD Counter Stock Code: 03012) (RMB Counter Stock Code: 83012) AMUNDI FTSE China A50 Index ETF (HKD Counter Stock Code: 02843) (RMB Counter Stock Code: 82843) (collectively, the Sub-Funds ) Announcement Amendment to short sales disclosure Unless otherwise stated, capitalised terms used in this Announcement shall have the same meaning ascribed to them in the prospectus of the Sub-Funds dated 26 October 2016 (the Prospectus ). A. Amendment to short sales disclosure The Prospectus currently discloses that a Sub-Fund shall not make short sales if as a result the Sub- Fund would be required to deliver Securities exceeding 10% of the Net Asset Value of the Sub-Fund (and for this purpose Securities sold short must be actively traded on a market where short selling is permitted). The Manager of the Sub-Funds, (the Manager ) hereby announces that, effective from 29 June 2018, an amendment will be made to the Prospectus to reflect that a Sub- Fund shall not make short sales (the Amendment ). B. Impact to the Sub-Funds The Amendment is being made as it reflects the current practice of the Sub-Funds more accurately. Since the inception of the Sub-Funds, none of the Sub-Funds has made any short sale. As such, (i) other than the Amendment, the investment objective and strategy of the Sub-Funds will remain unchanged; (ii) the Amendment will not amount to material change to the Sub-Funds; (iii) there will be no material change or increase in the overall risk profile of the Sub-Funds following the Amendment; and (iv) the Amendment will not materially prejudice the interests of Unitholders. 1

C. Prospectus and the Product Key Facts Statements The Amendment will be reflected in the revised Prospectus (by way of addendum), which will be published together with the updated Product Key Facts Statements of the Sub-Funds and this Announcement on the Sub-Funds website at www.amundietf.com.hk (this website has not been reviewed by the SFC) and Hong Kong Exchanges and Clearing Limited s website at www.hkex.com.hk. Investors who have any enquiries regarding the above may contact the Manager at 901 908, One Pacific Place, 88 Queensway, Hong Kong or at (852) 2521 4231 during normal office hours. as Manager of Amundi ETF Series and the Sub-Funds 29 June 2018 2

Important: The Stock Exchange of Hong Kong Limited (the SEHK ), Hong Kong Exchanges and Clearing Limited ( HKEx ), the Securities and Futures Commission ( SFC ) and the Hong Kong Securities Clearing Company Limited take no responsibility for the contents of this Announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Announcement. The Manager accepts full responsibility for the accuracy of the information contained in this Announcement as at the date of publication, and confirms, having made all reasonable enquiries, that to the best of its knowledge and belief, there are no other facts the omission of which would make any statement misleading and opinions expressed in this Announcement have been arrived at after due and careful consideration. SFC authorisation is not a recommendation or endorsement of a scheme nor does it guarantee the commercial merits of a scheme or its performance. It does not mean the scheme is suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors. If you are in doubt about the contents of this Announcement, you should consult your stockbroker, bank manager, solicitor, accountant or other professional adviser. Amundi Hang Seng HK 35 Index ETF (a sub-fund of Amundi ETF Series which is authorised under Section 104 of the Securities and Futures Ordinance (Cap. 571) of Hong Kong) (the Sub-Fund ) (HKD Counter Stock Code: 03012) (RMB Counter Stock Code: 83012) Announcement Interim Distribution Announcement, the Manager of the Sub-Fund, is pleased to announce the interim distribution. The dividend per unit is HKD0.34. Unitholders should pay attention the following important dates: Ex. Dividend Date Record Date Interim Distribution Date 15 June 2018 (Friday) 19 June 2018 (Tuesday) 10 July 2018 (Tuesday) as Manager of Amundi Hang Seng HK 35 Index ETF 1 June 2018

Important: The Stock Exchange of Hong Kong Limited (the SEHK ), Hong Kong Exchanges and Clearing Limited ( HKEx ), the Securities and Futures Commission ( SFC ) and the Hong Kong Securities Clearing Company Limited take no responsibility for the contents of this Announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Announcement. The Manager accepts full responsibility for the accuracy of the information contained in this Announcement as at the date of publication, and confirms, having made all reasonable enquiries, that to the best of its knowledge and belief, there are no other facts the omission of which would make any statement misleading and opinions expressed in this Announcement have been arrived at after due and careful consideration. SFC authorisation is not a recommendation or endorsement of a scheme nor does it guarantee the commercial merits of a scheme or its performance. It does not mean the scheme is suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors. If you are in doubt about the contents of this Announcement, you should consult your stockbroker, bank manager, solicitor, accountant or other professional adviser. Amundi ETF Series (a Hong Kong unit trust which is authorised under Section 104 of the Securities and Futures Ordinance (Cap. 571) of Hong Kong) Amundi Hang Seng HK 35 Index ETF (HKD Counter Stock Code: 03012) (RMB Counter Stock Code: 83012) Amundi FTSE China A50 Index ETF (HKD Counter Stock Code: 02843) (RMB Counter Stock Code: 82843) (Collectively, the Sub-Funds ) Announcement Interim report and unaudited accounts for the Sub-Funds Unless otherwise indicated, all undefined capitalised terms have the same meanings in this announcement as in the latest prospectus for the Sub-Funds. The Manager accepts responsibility for the accuracy, as at the date of this announcement, of the information contained in it. Dear Unitholders, The Manager is pleased to announce that the softcopy of the Sub-Fund s interim report and unaudited accounts in English for the period ending on 31 March 2018 (the Interim Report ) is available on the Manager s website at www.amundietf.com.hk and HKEx s website at www.hkex.com.hk from 31 May 2018. In addition, printed form of the Interim Report will be available at the office of Amundi Hong Kong Limited, the Manager of the Sub-Fund. Address of the Manager of the Sub-Fund: 901-908, One Pacific Place, 88 Queensway, Hong Kong 1

For enquiries, please contact at (852) 2521 4231. Yours faithfully, 31 May 2018 2

Important: The Stock Exchange of Hong Kong Limited (the SEHK ), Hong Kong Exchanges and Clearing Limited ( HKEx ), the Securities and Futures Commission ( SFC ) and the Hong Kong Securities Clearing Company Limited take no responsibility for the contents of this Announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Announcement. The Manager accepts full responsibility for the accuracy of the information contained in this Announcement as at the date of publication, and confirms, having made all reasonable enquiries, that to the best of its knowledge and belief, there are no other facts the omission of which would make any statement misleading and opinions expressed in this Announcement have been arrived at after due and careful consideration. SFC authorisation is not a recommendation or endorsement of a scheme nor does it guarantee the commercial merits of a scheme or its performance. It does not mean the scheme is suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors. If you are in doubt about the contents of this Announcement, you should consult your stockbroker, bank manager, solicitor, accountant or other professional adviser. Amundi ETF Series (a Hong Kong unit trust which is authorised under Section 104 of the Securities and Futures Ordinance (Cap. 571) of Hong Kong) Amundi Hang Seng HK 35 Index ETF (HKD Counter Stock Code: 03012) (RMB Counter Stock Code: 83012) Amundi FTSE China A50 Index ETF (HKD Counter Stock Code: 02843) (RMB Counter Stock Code: 82843) (Collectively, the Sub-Funds ) Announcement Annual report and audited accounts for the Sub-Funds Unless otherwise indicated, all undefined capitalised terms have the same meanings in this announcement as in the latest prospectus for the Sub-Funds. The Manager accepts responsibility for the accuracy, as at the date of this announcement, of the information contained in it. Dear Unitholders, The Manager is pleased to announce that the softcopy of the Sub-Fund s annual report and audited accounts in English for the period ending on 30 September 2017 (the Financial Statement ) is available on the Manager s website at www.amundietf.com.hk and HKEx s website at www.hkex.com.hk from 31 January 2018. In addition, printed form of the Financial Statement will be available at the office of Amundi Hong Kong Limited, the Manager of the Sub-Fund. Address of the Manager of the Sub-Fund: 901-908, One Pacific Place, 88 Queensway, Hong Kong 1

For enquiries, please contact at (852) 2521 4231. Yours faithfully, 31 January 2018 2

IMPORTANT: If you are in any doubt about the contents of this Addendum, you should consult your stockbroker, bank manager, solicitor, accountant and other financial adviser for independent financial advice. This Addendum forms an integral part of and should be read in conjunction with the Prospectus of Amundi ETF Series dated 26 October 2016 and the First Addendum thereto dated 28 April 2017 (collectively, the Prospectus ). The Prospectus may only be distributed if accompanied by this Addendum. The Manager accepts full responsibility for the accuracy of the information contained in this Announcement as at the date of publication, and confirms, having made all reasonable enquiries, that to the best of its knowledge and belief, there are no other facts the omission of which would make any statement misleading and opinions expressed in this Announcement have been arrived at after due and careful consideration. SFC authorisation is not a recommendation or an endorsement of a scheme nor does it guarantee the commercial merits of a scheme or its performance. It does not mean the scheme is suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors. AMUNDI ETF Series (a Hong Kong unit trust which is authorised under Section 104 of the Securities and Futures Ordinance (Cap. 571) of Hong Kong) AMUNDI Hang Seng HK 35 Index ETF (HKD Counter Stock Code: 03012) (RMB Counter Stock Code: 83012) AMUNDI FTSE China A50 Index ETF (HKD Counter Stock Code: 02843) (RMB Counter Stock Code: 82843) (Collectively, the Sub-Funds ) Second Addendum to the Prospectus The amendments set out in this Addendum shall take immediate effect. Unless otherwise specified, all capitalized terms shall have the same meaning as that in the Prospectus. (1) Under section headed Key Information on page 3 of the Appendix 2, the row for Initial Participating Dealers in the table is deleted in its entirety and replaced by a new row for Participating Dealers as follows: Participating Dealers ABN AMRO Clearing Hong Kong Limited BNP Paribas Securities Services The Hongkong and Shanghai Banking Corporation Limited Merrill Lynch Far East Limited Citigroup Global Markets Asia Limited China Merchants Securities (HK) Co., Limited 1

(2) Under section headed The offering phases on page 23 of the Appendix 2, the subsection headed Participating Dealers is deleted in its entirety and replaced by the following: Participating Dealers Each Participating Dealer has indicated to the Manager that it will generally accept and submit creation or redemption requests received from its clients, subject always to (i) mutual agreement between the relevant Participating Dealer and its clients as to its fees for handling such requests; (ii) completion to its satisfaction of client acceptance procedures and requirements; (iii) no objection from the Manager to create or redeem Units for the relevant Participating Dealer on behalf of such clients (please refer to the sub-section on Creation process and Redemption process for the examples of exceptional circumstances under which the Manager shall have the right to reject a Creation Application or Redemption Application); and (iv) mutual agreement between the relevant Participating Dealer and its clients as to the method of effecting such creation or redemption requests. (3) The top 10 index constituents weightings for the Sub-Funds have been updated. (i) AMUNDI Hang Seng HK 35 Index ETF The section Top 10 constituents on pages 14 15 of the Appendix 1 (as previously updated by the First Addendum dated 28 April 2017) is updated as follows: Top 10 constituents As at 23 June 2017, the 10 largest constituents of the Index, representing approximately, 62.05% of the market capitalisation of the Index based on total shares in issue, were as follows: Rank Constituent Name Weighting (%) 1. AIA 10.51 2. HSBC Holdings 9.98 3. CKH Holdings 8.16 4. HKEx 7.12 5. CK Property 5.01 6. CLP Holdings 4.83 7. SHK Ppt 4.64 8. Link REIT 4.08 9. BOC Hong Kong 3.91 10. HK & China Gas 3.81 You can obtain the most updated list of the constituents of the Index and additional information concerning the Index (including Index fact sheets, methodology, end of day Index levels and Index performance) from the website of the Index Provider at (www.hsi.com.hk). The Index (which is maintained by the Index Provider) is calculated and disseminated in HKD. (ii) AMUNDI FTSE China A50 Index ETF The section Top 10 constituents of the Index on page 31 of the Appendix 2 (as previously updated by the First Addendum dated 28 April 2017) is updated as follows: 2

Top 10 constituents of the Index As at 23 June 2017, the 10 largest constituents of the Index (which accounted in aggregate for 48.08% of the Index) were as follows: Rank Constituent Name Exchange Weighting (%) 1. Ping An Insurance-A Shanghai 10.68 2. China Merchants Bank-A Shanghai 6.32 3. Industrial Bank-A Shanghai 5.27 4. Kweichow Moutai-A Shanghai 4.88 5. China Minsheng Banking Corp-A Shanghai 4.36 6. Shanghai Pudong Dev Bank-A Shanghai 4.06 7. Midea Group-A Shenzhen 3.67 8. CITIC Securities-A Shanghai 3.07 9. Agriculture Bank of China-A Shanghai 2.89 10. Bank of Communications-A Shanghai 2.88 You can obtain the most updated list of the constituents of the Index and additional information of the Index from the website of FTSE at http://www.ftse.com/products/indices/china. as Manager of AMUNDI ETF Series and the Sub-Funds 30 June 2017 3